Drug resistance of infectious pathogens after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 2, 2006, Pages 190-194

  Zhou, Jian Dang ^a   Guo, Jian Jun ^a   Zhang, Qin ^a   Chen, Yin ^a   Zhu, Shai Hong ^a   Peng, Huai Yan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

AmpC lactamase; Bacteria; Drug resistance; Extended spectrum lactamase; Infection; Liver transplantation; Van gene

Indexed keywords

AGAR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; CEFEPIME; CEFTAZIDIME; DOXYCYCLINE; EXTENDED SPECTRUM BETA LACTAMASE; LEVOFLOXACIN; MEROPENEM; NITROCEFIN; OXACILLIN; PIPERACILLIN; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; DILUTION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RECIPIENT; SCLEROSING CHOLANGITIS; WILSON DISEASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; INFANT; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 33744812419     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Zheng SS, Wu J, Liang TB, Lu WD, Huang DS, Sheng Y, et al. Orthotpic Liver transplantation and infections: A report of 52 cases. J Surg Concepts Pract 2002;7:128-130.
2. Zhang D, Zhang ZT, Liu J, Gao DH, Wang Y. Bacterial infection after liver transplantation. Chin J Hepatobiliary Surg 2004;10:297-300.
3. Singh N, Cayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transplant 2001;7:22-26.
4. Zhou JD, Chen Y, Peng HY, Chen K, Qi Y. Pathogens and their drug-resistance after liver transplantation. Chin J Nosocomiol 2005;15:1192-1194.
5. Wang SQ, Zhang BX, eds. Hospital Acquired Infection. Chongqing: Scientechnology Press Chongqing branch;1990: 274-284.
6. Yuan Y, Xu YC, Chen MJ. Introduce of a detection method for the simultaneous presence of AmpC β-lactamases and ESBLs. China J Infect Chemother 2003;3:28-30
7. Zhang XZ, ed. Contemporary Laboratory and Clinical Bacteriology. Beijing: The People's Press; 1999:418-420.
8. Losada I, Cuervas-Mons V, Millan I, Damaso D. Early infection in liver transplant recipients: incidence, severity, risk factors and sensitivity of bacterial isolates. Enfem Infecc Microbiol Clin 2002;20:422-430.
9. Garcia S, Roque J, Ruza F. Infection and associated risk factor in the immediate postoperative period of pediatric liver transplantion: a study of 176 transplants. Clin Transpl 1998; 12:190-197.
10. Singh N. Infections complications in organ transplant recipients with the use of calcineurin-inhibitor agent-dased immunosuppressive regimens. Curr Opin Infect Dis 2005;18:342-345.
11. Schneider CR, Buell JF, Cearhart M, Thomas M, Hanaway MJ, Rudich SM, et al. Methicllin-resistant staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc 2005;37:1243-1244.
12. Singh N, Paterson DL, Chang FY, Gayowski T, Squier C, Wagener MM, et al. Methicillin-resistant staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000;30:322-327.
13. Singh N. Infections diseases in the liver transplant recipient. Semin Gastrointest Dis 1998;9:136-140.
14. Chen Y, Zhou JD, Peng HY. Distribution and resistant profile analyses of Gram-negative bacillus in our hospital, 1999-2001. Chin Antibiot 2003;28:724-726.
15. Liu GJ, Xu SZ, Ma Y, Li JY. Analysis of antimicrobial resistance of clinical isolates of enterococci from Beijing and other areas in China. Natl Med J China 2003;83:1049-1052.
16. Wang QT, Xu YC, Wang H, Chen MJ, Zhang XZ, Xu SZ, et al. Antimicrobial resistant characteristics in enterococci and antibiotics for enterococcal infections. Chin J Med Lab Sci 1999;22:154-156.
17. Kang M. The mechanism of drug-resistance to β-lactam antibiotics in Enterobaeteriaceac Cloacae. Guowai Yixue Weishengwuxue Fence (Foreign Med Microbiol Sci) 1997;2:21-24.
18. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC β-Lactamases among escherichia coli, klebaiella, pneumoniae an proteus mirabilis isolates at a Veterans Medical Center. J Clin Microbiol 2000;38:1791-1796.
19. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, et al. Characerization of clinical isolates of klebsiella pneumoniae from 19 laboratories using the NCCLS extended S pectrum β-Lactmases detection methods. J Clinic Microbiol 2001;39:2864-2872.
20. Bou G, Oliver A, Ojeda M, Monzon C, Martinez-Beltran J. Molecular characterization of FOX 4, a new AmpC type plasmid mediated lactamase from an Escherichia Coli strain isolated in Spain. Antimicrob Agents Chemother 2000;44:2549-2553.
21. Essack SY, Hall MC, Pillay DG, McFadyen ML, Livermore DM. Complexity and diversity of klebsiella pneumoniae strainswith extended spectrum β-Lactmases isolated in 1994 and 1996 at a Teaching Hospital in Durban, South Africa. Antimicrob Agents Chemother 2001;45:88-95.
22. Zhang YL, Li JQ, Zhao MW. Study on AmpC enzyme in Enterobacter cloacae. Chin Antibiot 2000;25:428-435.
23. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results form the Sentry Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:133-145.
24. Caballen-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Diez F, et al. Comparative study of bacteria caused by Enterococcal spp, with and with out high-level resistance to gentamicin. J Clin Microbiol 1998;36:520-525.
25. Mu XL, He XL, Zhou ZY, Xu JM, Hu BJ, Zhou CM, et al. Surveillance of lower respiratory tract infection of ESBL-producing strains and analysis of risk factors for acquisition. Chin J Nosocomid 2002;12:94-96.
26. She DY, Liu YY. Potential of six β-lactams to select matants with depressed AmpC β-lactams synthesis from enterobacter cloacae. Chin J Nosocomial Infect 2003;13:311-314.
27. Zhang KX, Tang YC, Zhang YB, Wu BQ, Bi XG, Tan SQ. Prognostic effect of vancomycin-resistant enterococci on nosocomial pulmonary infections caused by enterococci. Chin Antibiot 2003;28:246-248.
28. Denning DW, Evans EG, Kibbler CC, Richardson MD, Robert MM, Rogers TR, et al. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. Eur J Clin Microbicl Infect Dis 1997;16:424-436.
29. Greig P, Lilly L, Scudamroe C, Erb S, Voshida E, Kneteman N, et al. Early steroid with drawal after liver transplantation: the Canadion tacrolimus versus microemulsion cyclosporine A trial: 1-year follow-up. Liver Transplant 2003;9:587-595.
30. Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis 2002;4 (Suppl 3):S18-S23.
31. Zhou JD, Huang H, Chen Y, Peng HY. A pathoqenic study on gram negative bacilli infection in community. China Modern Med 2004;14:110-112.